| JAMA, The Journal of the American Medical Association 1998 Mark A. Wainberg |
| Title | Subject | Authors |
|---|
| A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. | Health | Stefano Vella, Brian Conway, Julio S.G. Montaner, David Cooper, Joep M.A. Lange, Peter Reiss, D. Smith, David Hall, Mark A. Wainberg, Maureen Myers, Patrick Robinson, Marianne Harris |
| Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 1.(Special Communication) | Health | Gerald Friedland, Mark A. Wainberg |
| Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 2.(Special Communication) | Health | Gerald Friedland, Mark A Wainberg |
| Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 3.(Special Communication) | Health | Gerald Friedland, Mark A Wainberg |
| Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 4.(Special Communication) | Health | Gerald Friedland, Mark A. Wainberg |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
